Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022

STORM recognised as an innovative early-stage biotechnology company pioneering novel drug targets

12 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes for oncology and other diseases, is pleased to announce that Fierce Biotech has named it as one of its 2022 “Fierce 15”, designating it as one of the most exciting biotechnology companies in the industry. This award highlights STORM’s dedication to developing novel treatments for the unmet medical need of patients, and its successes at the forefront of the RNA modification field.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH